ChemicalBook > Product Catalog >API >Antineoplastic agents >Other antineoplastic Drugs >Soravtansine

Soravtansine

Soravtansine Suppliers list
Company Name: Twochem Co.Ltd  
Tel: 021-021-58111628 15800915896
Email: sales@twochem.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Zhengzhou Converging Chemical Co. LTD  
Tel: 0371-53399770 18037166334
Email: 3857571523@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Soravtansine Basic information
Product Name:Soravtansine
Synonyms:Soravtansine;Sulfo-PDBA-DM4;Maytansine, N2'-[4-[(3-carboxy-3-sulfopropyl)dithio]-4-methyl-1-oxopentyl]-N2'-deacetyl-;Sulfo-PDBA-DM4, 98%,;4-[(4-{[(2S)-1-{[(1S,2R,3S,5S,6R,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.11?,1?.03,?]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy}-1-oxopropan-2-yl](methyl)carbamoyl}-2-methylbutan-2-yl)disulfanyl]-2-sulfobutanoic acid;Maytansine, N2′-[4-[(3-carboxy-3-sulfopropyl)dithio]-4-methyl-1-oxopentyl]-N2′-deacetyl- (ACI)
CAS:1461704-01-7
MF:C42H60ClN3O15S3
MW:978.58
EINECS:
Product Categories:
Mol File:1461704-01-7.mol
Soravtansine Structure
Soravtansine Chemical Properties
density 1.41±0.1 g/cm3(Predicted)
pka0.09±0.50(Predicted)
Safety Information
MSDS Information
Soravtansine Usage And Synthesis
UsesSulfo-PDBA-DM4 is a agent-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Sulfo-PDBA to make antibody agent conjugate (ADC). Sulfo-PDBA is a gluthatione cleavable linker.
IC 50Maytansinoids
References[1] Sun X, et al. Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates. Bioconjug Chem. 2017 May 17;28(5):1371-1381. DOI:10.1021/acs.bioconjchem.7b00062
Soravtansine Preparation Products And Raw materials
Tag:Soravtansine(1461704-01-7) Related Product Information
DBCO-PEG4-Val-Cit-PAB-MMAF L-Ornithinamide, N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-1... VcMMAE Val-Cit-PAB-MMAE Deruxtecan Mal-VC-PAB-DM1